247 related articles for article (PubMed ID: 6868553)
1. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
[TBL] [Abstract][Full Text] [Related]
2. The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis.
Naikhin AN; Tsaritsina IM; Oleinikova EV; Syrodoeva LG; Korchanova NL; Denisov GM; Shvartsman YaS
J Hyg (Lond); 1983 Aug; 91(1):131-8. PubMed ID: 6886409
[TBL] [Abstract][Full Text] [Related]
3. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus].
Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI
Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000
[TBL] [Abstract][Full Text] [Related]
4. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus].
Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM
Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840
[TBL] [Abstract][Full Text] [Related]
5. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
9. [Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].
Nikolova Z; Zakstel'skaia LIa; Kotseva R; Molibog EV
Vopr Virusol; 1975; (5):553-6. PubMed ID: 54996
[TBL] [Abstract][Full Text] [Related]
10. Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.
Natali A; Panizzi PF; Chezzi C; Oxford JS
J Hyg (Lond); 1984 Apr; 92(2):243-50. PubMed ID: 6707473
[TBL] [Abstract][Full Text] [Related]
11. [Strain specificity of the antineuraminidase antibodies of influenza virus serotype N2 strains in convalescents].
Molibog EV; Konstantinov-Zibelist I; Starke G; Zakstel'skaia LIa
Vopr Virusol; 1979; (6):631-4. PubMed ID: 524860
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine].
Nekliudova LI; Fedorova IuB; Orlova NG
Vopr Virusol; 1974; (2):173-6. PubMed ID: 4446555
[No Abstract] [Full Text] [Related]
13. [Homologous and heterologous antibody induction in influenzal infection and immunization].
Rudenko LG; Rafaél'skaia TI; Nesterenko LS
Vopr Virusol; 1977; (4):477-80. PubMed ID: 579009
[TBL] [Abstract][Full Text] [Related]
14. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
Stumpa A; Tůmová B
Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
[No Abstract] [Full Text] [Related]
15. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
16. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
Chow TC; Beutner KR; Ogra PL
Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
[TBL] [Abstract][Full Text] [Related]
18. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
Johansson BE; Moran TM; Bona CA; Kilbourne ED
J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
[TBL] [Abstract][Full Text] [Related]
19. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination].
Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP
Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404
[TBL] [Abstract][Full Text] [Related]
20. Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection.
Wong SS; Waite B; Ralston J; Wood T; Reynolds GE; Seeds R; Newbern EC; Thompson MG; Huang QS; Webby RJ;
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
